{"meshTagsMajor":["Mutation"],"meshTags":["Melanoma","Fatal Outcome","Female","Mutation","Pyrimidines","Benzamides","Drug Resistance, Neoplasm","Protein Kinase Inhibitors","Humans","Aged, 80 and over","Piperazines","Imatinib Mesylate","Proto-Oncogene Proteins c-kit"],"meshMinor":["Melanoma","Fatal Outcome","Female","Pyrimidines","Benzamides","Drug Resistance, Neoplasm","Protein Kinase Inhibitors","Humans","Aged, 80 and over","Piperazines","Imatinib Mesylate","Proto-Oncogene Proteins c-kit"],"publicationTypes":["Case Reports","Letter"],"title":"V559A and N822I double KIT mutant melanoma with predictable response to imatinib?","pubmedId":"21159146"}